Adamis Pharmaceuticals (ADMP) Hits New 52-Week High

Adamis Pharmaceuticals (ADMP) spiked to a new 52-week high of $8.12 before closing yesterday (02016.04.14) at $8.07. Three months ago, on 02016.01.20, ADMP hit an intra-day low of $3.63. Yesterday's volume was 419,290 vs. 64,592. [There are ~13.46 million ADMP shares.] The GDT::Portfolio average cost per ADMP is $6.23, so at least our investment is currently above water.

Adamis is "focused on developing and commercializing products in the therapeutic areas of allergy and respiratory disease."